|
1
|
Ip C: Prophylaxis of mammary neoplasia by
selenium supplementation in the initiation and promotion phases of
chemical carcinogenesis. Cancer Res. 41:4386–4390. 1981.PubMed/NCBI
|
|
2
|
Ip C, el-Bayoumi K, Upadhyaya P, Ganther
H, Vadhanavikit S and Thompson H: Comparative effect of inorganic
and organic selenocyanate derivatives in mammary cancer
chemoprevention. Carcinogenesis. 15:187–192. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lu J, Jiang C, Kaeck M, Ganther H,
Vadhanavikit S, Ip C and Thompson HJ: Cellular and metabolic
effects of triphenylselenonium chloride in a mammary cell culture
model. Carcinogenesis. 16:513–517. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sinha R, Said TK and Medina D: Organic and
inorganic selenium compounds inhibit mouse mammary cell growth in
vitro by different cellular pathways. Cancer Lett. 107:277–284.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Patterson BH and Levander OA: Naturally
occurring selenium compounds in cancer chemoprevention trials: a
workshop summary. Cancer Epidemiol Biomarkers Prev. 6:63–69.
1997.PubMed/NCBI
|
|
6
|
Stewart MS, Spallholtz JE, Neldner KH and
Pence BC: Selenium compounds have disparate abilities to impose
oxidative stress and induce apoptosis. Free Redic Biol Med.
26:42–48. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Qiao YL, Dawsey SM, Kamangar F, Fan JH,
Abnet CC, Sun XD, Johnson LL, Gail MH, Dong ZW, Yu B, Mark SD and
Taylor PR: Total and cancer mortality after supplementation with
vitamins and minerals: follow-up of the Linxian General Population
Nutrition Intervention Trial. J Natl Cancer Inst. 101:507–518.
2009. View Article : Google Scholar
|
|
8
|
Venkateswaran V, Klotz LH, Ramani M, Sugar
LM, Jacob LE, Nam RK and Fleshner NE: A combination of
micronutrients is beneficial in reducing the incidence of prostate
cancer and increasing survival in the Lady transgenic model. Cancer
Prev Res. 2:473–483. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Clark LC, Combs GF Jr, Turnbull BW, Slate
EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG,
Krongrad A, Lesher JL Jr, Park HK, Sanders BB Jr, Smith CL and
Taylor JR: Effects of selenium supplementation for cancer
prevention in patients with carcinoma of the skin. A randomized
controlled trial. Nutritional Prevention of Cancer Study Group.
JAMA. 276:1957–1963. 1996. View Article : Google Scholar
|
|
10
|
Heinonen OP, Albanes D, Virtamo J, Taylor
PR, Huttunen JK, Hartman AM, Haapakoski J, Malila N, Rautalahti M,
Ripatti S, Mäenpää H, Teerenhovi L, Koss L, Virolainen M and
Edwards BK: Prostate cancer and supplementation with α-tocopherol
and β-carotene: incidence and mortality in a controlled trial. J
Natl Cancer Inst. 90:440–446. 1998.
|
|
11
|
Seo YR, Kelley MR and Smith ML:
Selenomethionine regulation of p53 by a ref1-dependent redox
mechanism. Proc Natl Acad Sci USA. 99:14548–14553. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ko LJ and Prives C: p53: puzzle and
paradigm. Genes Dev. 10:1054–1072. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Giaccia AJ and Kastan MB: The complexity
of p53 modulation: emerging patterns from divergent signals. Genes
Dev. 12:2973–2983. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Prives C and Hall PA: The p53 pathway. J
Pathol. 187:112–126. 1999. View Article : Google Scholar
|
|
15
|
Lane DP: Cancer. p53, guardian of the
genome. Nature. 358:15–16. 1992. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liebermann DA, Hoffman B and Steinman RA:
Molecular controls of growth arrest and apoptosis: p53-dependent
and independent pathways. Oncogene. 11:199–210. 1995.PubMed/NCBI
|
|
17
|
Hwang BJ, Ford JM, Hanawalt PC and Chu G:
Expression of the p48 xeroderma pigmentosum gene is p53-dependent
and is involved in global genomic repair. Proc Natl Acad Sci USA.
96:424–428. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jung HJ, Lee JH and Seo YR: Enhancement of
methyl methanesulfonate-induced base excision repair in the
presence of selenomethionine on p53-dependent pathway. J Med Food.
12:340–344. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Smith ML, Ford JM, Hollander MC, Bortnick
RA, Amundson SA, Seo YR, Deng CX, Hanawalt PC and Fornace AJ Jr:
P53-mediated DNA repair responses to UV-radiation: studies of mouse
cells lacking p53, p21, and/or gadd45 genes. Mol Cell Biol.
20:3705–3714. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Smith ML, Chen IT, Zhan Q, Bae I, Chen CY,
Gilmer TM, Kastan MB, O’Connor PM and Fornace AJ Jr: Interaction of
the p53-regulated protein Gadd45 with proliferating cell nuclear
antigen. Science. 266:1376–1380. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xia L, Zheng L, Lee HW, Bates SE, Federico
L, Shen B and O’Connor TR: Human 3-methyladenine DNA glycosylase:
effect of sequence context on excision, association with PCNA, and
stimulation by AP endonuclease. J Mol Biol. 346:1259–1274. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jung HJ, Kim EH, Mun JY, Park S, Smith ML,
Han SS and Seo YR: Base excision DNA repair defect in
Gadd45a-deficient cells. Oncogene. 26:7517–7525. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kastan MB, Zhan Q, el-Deiry WS, Carrier F,
Jacks T, Walsh WV, Plunkett BS, Vogelstein B and Fornace AJ Jr: A
mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is
defective in ataxia-telangiectasia. Cell. 71:587–597. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Smith ML, Chen IT, Zhan Q, O’Connor PM and
Fornace AJ Jr: Involvement of the p53 tumor suppressor in repair of
u.v.-type DNA damage. Oncogene. 10:1053–1059. 1995.PubMed/NCBI
|
|
25
|
Seeberg E, Eide L and Bjørås M: The base
excision repair pathway. Trans Biochem Sci. 20:391–397. 1995.
View Article : Google Scholar
|
|
26
|
Sung JS and Demple B: Roles of base
excision repair subpathways in correcting oxidized abasic sites in
DNA. FEBS J. 273:1620–1629. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lindahl T and Andersson A: Rate of chain
breakage at apurinic sites in double-stranded deoxyribonucleic
acid. Biochemistry. 11:3618–3623. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lindahl T and Nyberg B: Rate of
depurination of native deoxyribonucleic acid. Biochemistry.
11:3610–3618. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lippman SM, Klein EA, Goodman PJ, Lucia
MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM,
Hartline JA, Parsons JK, Bearden JD III, Crawford ED, Goodman GE,
Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM,
Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D,
Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL Jr,
Baker LH and Coltman CA Jr: Effect of selenium and vitamin E on
risk of prostate cancer and other cancers: the Selenium and Vitamin
E Cancer Prevention Trial (SELECT). JAMA. 301:39–51. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gaiddon C, Moorthy NC and Prives C: Ref-1
regulates the transactivation and pro-apoptotic functions of p53 in
vivo. EMBO J. 18:5609–5621. 1999. View Article : Google Scholar
|
|
31
|
Offer H, Zurer I, Banfalvi G, Reha’k M,
Falcovitz A, Milyavsky M, Goldfinger N and Rotter V: p53 modulates
base excision repair activity in a cell cycle-specific manner after
genotoxic stress. Cancer Res. 61:88–96. 2001.PubMed/NCBI
|
|
32
|
Zhou J, Ahn J, Wilson SH and Prives C: A
role for p53 in base excision repair. EMBO J. 20:914–923. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lee YS and Chung MH: Base excision repair
synthesis of DNA containing 8-oxoguanine in Escherichia
coli. Exp Mol Med. 35:106–112. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Adimoolam S and Ford JM: p53 and DNA
damage-inducible expression of the xeroderma pigmentosum group C
gene. Proc Natl Acad Sci USA. 99:12985–12990. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Vairapandi M, Azam N, Balliet AG, Hoffman
B and Liebermann DA: Characterization of MyD118, Gadd45, and
proliferating cell nuclear antigen (PCNA) interacting domains. PCNA
impedes MyD118 and Gadd45-mediated negative growth control. J Biol
Chem. 275:16810–16819. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Seo YR, Sweeney C and Smith ML:
Selenomethionine induction of DNA repair response in human
fibroblasts. Oncogene. 21:3663–3669. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hanson S, Kim E and Deppert W: Redox
factor 1 (Ref-1) enhances specific DNA binding of p53 by promoting
p53 tetramerization. Oncogene. 24:1641–1647. 2005. View Article : Google Scholar : PubMed/NCBI
|
